EP3960013B1 - Method of manufacturing a glove and a glove - Google Patents
Method of manufacturing a glove and a glove Download PDFInfo
- Publication number
- EP3960013B1 EP3960013B1 EP20193029.4A EP20193029A EP3960013B1 EP 3960013 B1 EP3960013 B1 EP 3960013B1 EP 20193029 A EP20193029 A EP 20193029A EP 3960013 B1 EP3960013 B1 EP 3960013B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- glove
- lining
- pathogen inactivating
- top layer
- inactivating compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 9
- 244000052769 pathogen Species 0.000 claims description 60
- 150000001875 compounds Chemical class 0.000 claims description 54
- 230000000415 inactivating effect Effects 0.000 claims description 54
- 230000001717 pathogenic effect Effects 0.000 claims description 52
- 238000000034 method Methods 0.000 claims description 23
- 239000000126 substance Substances 0.000 claims description 23
- 239000007788 liquid Substances 0.000 claims description 18
- 239000011248 coating agent Substances 0.000 claims description 12
- 238000000576 coating method Methods 0.000 claims description 12
- 239000004744 fabric Substances 0.000 claims description 8
- 239000010985 leather Substances 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 6
- 150000007513 acids Chemical class 0.000 claims description 6
- 239000011347 resin Substances 0.000 claims description 6
- 229920005989 resin Polymers 0.000 claims description 6
- 239000004753 textile Substances 0.000 claims description 6
- 239000000463 material Substances 0.000 description 9
- 238000005507 spraying Methods 0.000 description 6
- 238000009940 knitting Methods 0.000 description 5
- 239000007921 spray Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 229920003052 natural elastomer Polymers 0.000 description 3
- 229920001194 natural rubber Polymers 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 229920003051 synthetic elastomer Polymers 0.000 description 3
- 239000005061 synthetic rubber Substances 0.000 description 3
- 244000223014 Syzygium aromaticum Species 0.000 description 2
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000002940 repellent Effects 0.000 description 2
- 239000005871 repellent Substances 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 239000002759 woven fabric Substances 0.000 description 2
- 241000233866 Fungi Species 0.000 description 1
- 241000197306 H1N1 subtype Species 0.000 description 1
- 208000025370 Middle East respiratory syndrome Diseases 0.000 description 1
- 201000003176 Severe Acute Respiratory Syndrome Diseases 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- -1 glycol ethers Chemical class 0.000 description 1
- 210000004247 hand Anatomy 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 238000009958 sewing Methods 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 241000007181 unidentified human coronavirus Species 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A41—WEARING APPAREL
- A41D—OUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
- A41D19/00—Gloves
- A41D19/0006—Gloves made of several layers of material
-
- A—HUMAN NECESSITIES
- A41—WEARING APPAREL
- A41D—OUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
- A41D19/00—Gloves
- A41D19/001—Linings
-
- A—HUMAN NECESSITIES
- A41—WEARING APPAREL
- A41D—OUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
- A41D19/00—Gloves
- A41D19/015—Protective gloves
-
- A—HUMAN NECESSITIES
- A41—WEARING APPAREL
- A41D—OUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
- A41D2500/00—Materials for garments
- A41D2500/10—Knitted
-
- A—HUMAN NECESSITIES
- A41—WEARING APPAREL
- A41D—OUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
- A41D2500/00—Materials for garments
- A41D2500/20—Woven
Definitions
- the invention relates to method of manufacturing a glove and a glove, which glove comprises top layer, an outer surface and an inner surface, which inner surface is configured to be in skin contact when the glove is worn in hand.
- Pathogens such as bacteria and viruses cause diseases, which may be difficult to cure and require a long time to recover. Some diseases may even fatal.
- On way to reduce the risk of having a contamination of harmful pathogens is to wear gloves. By wearing gloves skin contacts with possibly contaminated surfaces can be reduced. Gloves are widely used in occupations and workplaces, where there is an increased risk of being infected by harmful pathogens.
- the gloves used to reduce infection risk are disposable, i.e. they are not intended to be reused after removal.
- Disposable protective gloves are difficult to put on and take off and their mechanical durability is weak. Gloves are effective in avoiding contamination only, if the hands are disinfected before the gloves are put on. Therefore, gloves lose their protective effect easily in everyday use, where occasional removing the gloves is necessary. Problems relating to the use of the disposable gloves lower the willingness of the people to use gloves for protection.
- An object of the invention is to provide a method for manufacturing a glove and a glove, with which drawbacks relating to the prior art can be reduced.
- the present invention relates to a method of manufacturing a glove, which glove comprises top layer, an outer surface and an inner surface, which inner surface is configured to be in skin contact when the glove is worn in hand.
- Said method comprises a step of providing the inner surface with pathogen inactivating compounds whereby the inner surface is treated with a substance containing pathogen inactivating compounds, said substance comprising solvent and coniferous resin acids in the range of 0,01 to 30 weight-% of the substance.
- the method comprises a step of manufacturing a lining, said lining having an inner surface and attaching the lining inside the top layer, whereby the inner surface of the lining forms the inner surface of the glove.
- liquid containing pathogen inactivating compounds is sprayed on the inner surface and the sprayed liquid is allowed to dry to a coating at least partly covering the inner surface.
- the glove is soaked in a liquid containing pathogen inactivating compounds to impregnate the glove with pathogen inactivating compounds and the soaked glove is allowed to dry.
- the lining is soaked in a liquid containing pathogen inactivating compounds to impregnate the lining with pathogen inactivating compounds and the soaked lining is allowed to dry.
- the lining is soaked in a liquid containing pathogen inactivating compounds before the lining is attached inside the top layer.
- the lining is manufactured of fabrics or of threads which fabrics or threads are treated with a substance containing pathogen inactivating compounds before the lining is manufactured.
- the top layer is treated with a substance containing pathogen inactivating compounds before the lining is attached inside the top layer.
- a glove according to the invention comprises a top layer, an outer surface and an inner surface, which inner surface is configured to be in skin contact when the glove is worn in hand.
- Said inner surface contains pathogen inactivating compounds, wherein said pathogen inactivating compounds comprise coniferous resin acids.
- the glove comprises a lining inside the top layer, said lining having an inner surface, whereby the inner surface of the lining forms the inner surface of the glove.
- the inner surface has a coating comprising pathogen inactivating compounds.
- the top layer and/or the lining is impregnated with pathogen inactivating compounds.
- the top layer is made of leather or textile and the outer surface of the glove has a coating comprising pathogen inactivating compounds.
- An advantage of the invention is, that it reduces the risk on being infected by pathogens in everyday situations.
- Another advantage of the invention is, that the reduces the need and use of disposable gloves, which saves material and environment.
- a further advantage of the invention is, that it reduces the need of using disinfectants.
- FIG 1a an embodiment of the glove according to the invention is shown oblique from above.
- fig. 1b a cross-section the glove of fig. 1a along line A-A is depicted. In the following both figures are explained simultaneously.
- the glove is a known handheld garment comprising a top layer 10, which has a shape of a hand.
- the top layer can be made by knitting or by sewing cutted pieces of fabrics or leather together to a desired shape. Further, it is possible to make the top layer from castable material, such as natural or synthetic rubber or plastic by using a mould having a shape of a hand.
- the top layer 10 has an outer surface 12 and an inner surface 14 ( fig. 1b ).
- the inner surface is defined to be the surface, which is configured to be in skin contact, when the glove is worn in hand.
- the outer surface is the surface of the top layer, which remains visible, when a hand is inserted inside the glove.
- the inner surface 14 is treated with a substance containing pathogen inactivating compounds.
- pathogen inactivating compounds adhere to inner surface forming a pathogen inactivating coating covering substantially the whole area of the inner surface.
- Pathogens may include bacteria, viruses and/or fungus. Inactivating here means making the pathogens harmless either by killing them or by significantly reducing their ability to reproduce on animate or inanimate surface and/or infect a human being.
- the treatment can be made by immersing the substantially finished glove into a liquid containing pathogen inactivating compounds. The soaked glove is then lifted out of the liquid and allowed to dry completely. When the glove dries the molecules of the pathogen inactivating compounds form a dense network on the inner surface and on the outer surface of the clove. If the top layer is knitted or woven fabric or textile or other fibrous material, which is water permeable, the compounds form a covering around the fibres of the top layer. Thus, the whole top layer material becomes impregnated with pathogen inactivating compounds.
- top layer is made of substantially waterproof material, such as leather, natural or synthetic rubber, plastic, water repellent or waterproof fabric or PU-coated textile, a coating in a form of thin molecular net containing pathogen inactivating compounds is formed and adhered to the inner and outer surfaces of the glove.
- substantially waterproof material such as leather, natural or synthetic rubber, plastic, water repellent or waterproof fabric or PU-coated textile
- the treatment with a substance containing pathogen inactivating compounds is made by spraying liquid containing pathogen inactivating compounds on the inner surface 14 of the glove and allowing the sprayed liquid to dry to a coating on the inner surface.
- a single spray treatment comprises a number of consecutive sprayings and a drying period between each spraying.
- the number of sprayings in a single spray treatment may be 10 to 20, preferably 15.
- the drying period between each spraying may be 5 to 10 minutes.
- the top layer of the glove can be turned inside up for the duration of the spray treatment.
- a similar spray treatment can be made for the outer surface of the glove also.
- FIG 2a a second embodiment of the glove according to the invention is seen oblique from above.
- fig. 2b a cross-section the glove of fig. 2a along line B-B is depicted. In the following both figures are explained simultaneously.
- the embodiment of the glove depicted in figs. 2a and 2b differs from the embodiment of figs. 1a and 1b in that it further comprises a lining 18 inside the top layer 10.
- the lining and the top layer have a substantially similar shape, but the lining is slightly smaller, which makes possible to insert the lining inside the top layer.
- the inner surface of the glove which is defined to be the surface, which is configured to be in skin contact, when the glove is worn in hand, is now the inner surface 14a of the lining 18.
- the lining is usually made of soft knitted or woven fabric or textile.
- the lining is attached to the top layer 10 by joint knitting 16 locating in the edge of the wrist surrounding area of the glove.
- the treatment for a glove shown in figs 2a and 2b with a substance containing pathogen inactivating compounds can be made in a similar way as to the gloves shown in figs. 1a and 1b , i.e. by immersing the substantially finished glove into a liquid containing pathogen inactivating compounds and allowing glove to dry completely.
- the water permeable lining material becomes impregnated with pathogen inactivating compounds and on the inner surface 14a of the lining a coating containing pathogen inactivating compounds is formed.
- the top layer becomes impregnated in a similar manner.
- top layer is made of substantially waterproof material, such as leather, natural or synthetic rubber, plastic, water repellent or waterproof fabric or PU-coated textile, a thin coating containing pathogen inactivating compounds is formed and adhered to the inner and outer surfaces of the top layer.
- This soaking treatment is a possible treatment method for cloves, if the material of the outer surface of the glove can withstand soaking and wetting without harmful side-effects, such as colour chances.
- the treatment of the lining 18 and the treatment of the top layer 10 are made in separate phases.
- the treatment of the lining 18 can be made either by immersing the substantially finished lining into a liquid containing pathogen inactivating compounds and allowing the lining to dry completely or by spraying liquid containing pathogen inactivating compounds at least on the inner surface 14a of the lining and allowing the sprayed liquid to dry as explained above.
- the lining can be detached from the top layer whereby it is attached to the top layer with a joint knitting 16 after the treatment of the lining is finished. It is also possible to attach the lining to the top layer before treatment and pull the lining out the top layer in a way that only a short strip of lining next to joint knitting remains inside the top layer.
- the treatment with a substance containing pathogen inactivating compounds is performed. After the treatment is finished and the lining 18 is dry, the lining is pushed back inside the top layer. Further, it possible to treat the manufacturing materials of the lining, i.e. the yarns and fabrics, already before the manufacturing of the lining is started.
- the substance containing pathogen inactivating compounds used in the method contains natural, biodegradable compounds, which are harmless for the human and for the environment.
- the substance comprises solvent and coniferous resin acids in the range of 0,01 to 30 weight-% of the substance.
- the substance comprises primary solvent, coniferous resin acids in the range of 0,01 to 30 weight %, water and an auxiliary solvent selected from E and P series glycol ethers.
- the amount of primary solvent is preferably in the range from 50 to 95 weight -% and the amount of auxiliary solvent is preferably in the range from 0,001 weight-% to 5 weight -% of the substance.
- Aforementioned substance has an inactivating effect to numerous bacteria and viruses including SARS, MERS, influenza virus, H1N1 and human coronavirus.
- the substance has also proven to have adequate adhesion properties, i.e. it sticks and stays in on the inner and outer surface of the glove for an expected lifetime of the glove.
- the used substance does not include heavy metals, borax, terbinafines, parabens or quaternary ammonium compounds.
- the inner surface of the glove according to the invention contains aforementioned pathogen inactivating compounds.
- the glove When the glove is used, i.e. when a hand is inserted inside the glove, the hand is in skin contact with the inner surface and the compounds therein. If the hand carries pathogens, such as bacteria or viruses, the compounds in the inners surface will soon inactivate them. Thus, a hand is disinfected each time the hand is inserter and kept inside a glove for a sufficient time.
- the glove according to the invention may be a workglove or a leisure time glove. These kinds of gloves are usually kept in hand quite long periods, whereby the pathogen inactivating compounds easily have sufficient time to influence to the pathogens.
Description
- The invention relates to method of manufacturing a glove and a glove, which glove comprises top layer, an outer surface and an inner surface, which inner surface is configured to be in skin contact when the glove is worn in hand.
- Pathogens, such as bacteria and viruses cause diseases, which may be difficult to cure and require a long time to recover. Some diseases may even fatal. On way to reduce the risk of having a contamination of harmful pathogens is to wear gloves. By wearing gloves skin contacts with possibly contaminated surfaces can be reduced. Gloves are widely used in occupations and workplaces, where there is an increased risk of being infected by harmful pathogens. Usually, the gloves used to reduce infection risk are disposable, i.e. they are not intended to be reused after removal. Disposable protective gloves are difficult to put on and take off and their mechanical durability is weak. Gloves are effective in avoiding contamination only, if the hands are disinfected before the gloves are put on. Therefore, gloves lose their protective effect easily in everyday use, where occasional removing the gloves is necessary. Problems relating to the use of the disposable gloves lower the willingness of the people to use gloves for protection.
- Documents
WO 2008/014423 A2 ,US 2017/055607 A1 andEP 1537796 A2 disclose gloves containing pathogen inactivating compound on the inner surface of the glove. An object of the invention is to provide a method for manufacturing a glove and a glove, with which drawbacks relating to the prior art can be reduced. - The object of the invention is achieved with a method and a glove which are characterized in what is disclosed in the independent patent claims. Some preferred embodiments of the invention are disclosed in the dependent claims.
- The present invention relates to a method of manufacturing a glove, which glove comprises top layer, an outer surface and an inner surface, which inner surface is configured to be in skin contact when the glove is worn in hand. Said method comprises a step of providing the inner surface with pathogen inactivating compounds whereby the inner surface is treated with a substance containing pathogen inactivating compounds, said substance comprising solvent and coniferous resin acids in the range of 0,01 to 30 weight-% of the substance.
- In a preferred embodiment, the method comprises a step of manufacturing a lining, said lining having an inner surface and attaching the lining inside the top layer, whereby the inner surface of the lining forms the inner surface of the glove.
- In a second preferred embodiment of the method according to the invention liquid containing pathogen inactivating compounds is sprayed on the inner surface and the sprayed liquid is allowed to dry to a coating at least partly covering the inner surface.
- In a third preferred embodiment of the method according to the invention the glove is soaked in a liquid containing pathogen inactivating compounds to impregnate the glove with pathogen inactivating compounds and the soaked glove is allowed to dry. In yet another preferred embodiment of the method according to the invention the lining is soaked in a liquid containing pathogen inactivating compounds to impregnate the lining with pathogen inactivating compounds and the soaked lining is allowed to dry. Preferably, the lining is soaked in a liquid containing pathogen inactivating compounds before the lining is attached inside the top layer.
- In yet another preferred embodiment of the method according to the invention the lining is manufactured of fabrics or of threads which fabrics or threads are treated with a substance containing pathogen inactivating compounds before the lining is manufactured.
- In yet another preferred embodiment of the method according to the invention the top layer is treated with a substance containing pathogen inactivating compounds before the lining is attached inside the top layer.
- A glove according to the invention comprises a top layer, an outer surface and an inner surface, which inner surface is configured to be in skin contact when the glove is worn in hand. Said inner surface contains pathogen inactivating compounds, wherein said pathogen inactivating compounds comprise coniferous resin acids. Preferably, the glove comprises a lining inside the top layer, said lining having an inner surface, whereby the inner surface of the lining forms the inner surface of the glove. In a preferred embodiment of the glove according to the invention the inner surface has a coating comprising pathogen inactivating compounds.
- In a second preferred embodiment of the glove according to the invention the top layer and/or the lining is impregnated with pathogen inactivating compounds.
- In yet another preferred embodiment of the glove according to the invention the top layer is made of leather or textile and the outer surface of the glove has a coating comprising pathogen inactivating compounds.
- An advantage of the invention is, that it reduces the risk on being infected by pathogens in everyday situations.
- Another advantage of the invention is, that the reduces the need and use of disposable gloves, which saves material and environment.
- A further advantage of the invention is, that it reduces the need of using disinfectants.
- In the following the invention will be described in detail, by way of examples, with reference to the accompanying drawings in which,
- Fig. 1a
- shows one preferred embodiment of a glove according to the invention seen obliquely from above,
- Fig. 1b
- shows a cross-section of the embodiment of the glove depicted in
fig. 1a , - Fig. 2a
- shows another preferred embodiment of a glove according to the invention seen obliquely from above and
- Fig. 2b
- shows a cross-section of the embodiment of the glove depicted in
fig. 2a . - In
figure 1a an embodiment of the glove according to the invention is shown oblique from above. Infig. 1b a cross-section the glove offig. 1a along line A-A is depicted. In the following both figures are explained simultaneously. - The glove is a known handheld garment comprising a
top layer 10, which has a shape of a hand. The top layer can be made by knitting or by sewing cutted pieces of fabrics or leather together to a desired shape. Further, it is possible to make the top layer from castable material, such as natural or synthetic rubber or plastic by using a mould having a shape of a hand. Thetop layer 10 has anouter surface 12 and an inner surface 14 (fig. 1b ). Here the inner surface is defined to be the surface, which is configured to be in skin contact, when the glove is worn in hand. The outer surface is the surface of the top layer, which remains visible, when a hand is inserted inside the glove. - In the method according to the invention the
inner surface 14 is treated with a substance containing pathogen inactivating compounds. As a result of this treatment pathogen inactivating compounds adhere to inner surface forming a pathogen inactivating coating covering substantially the whole area of the inner surface. Pathogens may include bacteria, viruses and/or fungus. Inactivating here means making the pathogens harmless either by killing them or by significantly reducing their ability to reproduce on animate or inanimate surface and/or infect a human being. - The treatment can be made by immersing the substantially finished glove into a liquid containing pathogen inactivating compounds. The soaked glove is then lifted out of the liquid and allowed to dry completely. When the glove dries the molecules of the pathogen inactivating compounds form a dense network on the inner surface and on the outer surface of the clove. If the top layer is knitted or woven fabric or textile or other fibrous material, which is water permeable, the compounds form a covering around the fibres of the top layer. Thus, the whole top layer material becomes impregnated with pathogen inactivating compounds. If the top layer is made of substantially waterproof material, such as leather, natural or synthetic rubber, plastic, water repellent or waterproof fabric or PU-coated textile, a coating in a form of thin molecular net containing pathogen inactivating compounds is formed and adhered to the inner and outer surfaces of the glove.
- In a second preferred embodiment of the invention the treatment with a substance containing pathogen inactivating compounds is made by spraying liquid containing pathogen inactivating compounds on the
inner surface 14 of the glove and allowing the sprayed liquid to dry to a coating on the inner surface. Preferably, a single spray treatment comprises a number of consecutive sprayings and a drying period between each spraying. The number of sprayings in a single spray treatment may be 10 to 20, preferably 15. The drying period between each spraying may be 5 to 10 minutes. The top layer of the glove can be turned inside up for the duration of the spray treatment. Naturally, a similar spray treatment can be made for the outer surface of the glove also. - In
figure 2a a second embodiment of the glove according to the invention is seen oblique from above. Infig. 2b a cross-section the glove offig. 2a along line B-B is depicted. In the following both figures are explained simultaneously. - The embodiment of the glove depicted in
figs. 2a and 2b differs from the embodiment offigs. 1a and 1b in that it further comprises a lining 18 inside the top layer 10.The lining and the top layer have a substantially similar shape, but the lining is slightly smaller, which makes possible to insert the lining inside the top layer. In the embodiment offigs 2a and 2b the inner surface of the glove, which is defined to be the surface, which is configured to be in skin contact, when the glove is worn in hand, is now theinner surface 14a of thelining 18. One purpose of the lining is to increase the comfort of the use of the glove. Therefore, the lining is usually made of soft knitted or woven fabric or textile. The lining is attached to thetop layer 10 byjoint knitting 16 locating in the edge of the wrist surrounding area of the glove. - The treatment for a glove shown in
figs 2a and 2b with a substance containing pathogen inactivating compounds can be made in a similar way as to the gloves shown infigs. 1a and 1b , i.e. by immersing the substantially finished glove into a liquid containing pathogen inactivating compounds and allowing glove to dry completely. The water permeable lining material becomes impregnated with pathogen inactivating compounds and on theinner surface 14a of the lining a coating containing pathogen inactivating compounds is formed. The top layer becomes impregnated in a similar manner. If the top layer is made of substantially waterproof material, such as leather, natural or synthetic rubber, plastic, water repellent or waterproof fabric or PU-coated textile, a thin coating containing pathogen inactivating compounds is formed and adhered to the inner and outer surfaces of the top layer. This soaking treatment is a possible treatment method for cloves, if the material of the outer surface of the glove can withstand soaking and wetting without harmful side-effects, such as colour chances. - In another preferred embodiment of the invention the treatment of the
lining 18 and the treatment of thetop layer 10 are made in separate phases. The treatment of the lining 18 can be made either by immersing the substantially finished lining into a liquid containing pathogen inactivating compounds and allowing the lining to dry completely or by spraying liquid containing pathogen inactivating compounds at least on theinner surface 14a of the lining and allowing the sprayed liquid to dry as explained above. - During the treatment the lining can be detached from the top layer whereby it is attached to the top layer with a
joint knitting 16 after the treatment of the lining is finished. It is also possible to attach the lining to the top layer before treatment and pull the lining out the top layer in a way that only a short strip of lining next to joint knitting remains inside the top layer. When the lining is pulled outside of the glove, the treatment with a substance containing pathogen inactivating compounds is performed. After the treatment is finished and the lining 18 is dry, the lining is pushed back inside the top layer. Further, it possible to treat the manufacturing materials of the lining, i.e. the yarns and fabrics, already before the manufacturing of the lining is started. - These embodiments of the invention, where the treatment of the lining and top layer are separated, are especially suitable for gloves, in which the material properties of the lining and the top layer are diverging. For example, an immersing treatment method is probably not a best choice for a top layer made of coloured leather. For leather gloves the top layer can be treated with a more sensitive spray treatment. It is also possible to leave the top layer totally without the treatment and pathogen inactivating coating.
- The substance containing pathogen inactivating compounds used in the method contains natural, biodegradable compounds, which are harmless for the human and for the environment. According to the invention the substance comprises solvent and coniferous resin acids in the range of 0,01 to 30 weight-% of the substance.
- Preferably, the substance comprises primary solvent, coniferous resin acids in the range of 0,01 to 30 weight %, water and an auxiliary solvent selected from E and P series glycol ethers. The amount of primary solvent is preferably in the range from 50 to 95 weight -% and the amount of auxiliary solvent is preferably in the range from 0,001 weight-% to 5 weight -% of the substance.
- Aforementioned substance has an inactivating effect to numerous bacteria and viruses including SARS, MERS, influenza virus, H1N1 and human coronavirus. The substance has also proven to have adequate adhesion properties, i.e. it sticks and stays in on the inner and outer surface of the glove for an expected lifetime of the glove.
- Aforementioned properties make the substance suitable for the method and glove according to the invention. Preferably, the used substance does not include heavy metals, borax, terbinafines, parabens or quaternary ammonium compounds.
- The inner surface of the glove according to the invention contains aforementioned pathogen inactivating compounds. When the glove is used, i.e. when a hand is inserted inside the glove, the hand is in skin contact with the inner surface and the compounds therein. If the hand carries pathogens, such as bacteria or viruses, the compounds in the inners surface will soon inactivate them. Thus, a hand is disinfected each time the hand is inserter and kept inside a glove for a sufficient time. The glove according to the invention may be a workglove or a leisure time glove. These kinds of gloves are usually kept in hand quite long periods, whereby the pathogen inactivating compounds easily have sufficient time to influence to the pathogens.
- Above, some preferred embodiments of the invention are explained. The invention is not limited to the solutions described above, but the inventive idea can be applied in numerous ways within the scope of the claims.
-
- 10
- top layer
- 12
- outer surface
- 14
- inner surface
- 14a
- inner surface of the lining
- 16
- joint knitting
- 18
- lining
Claims (13)
- A method of manufacturing a glove, which glove comprises top layer (10), an outer surface (12) and an inner surface (14), which inner surface is configured to be in skin contact when the glove is worn in hand and which method comprises a step of providing the inner surface (14) with pathogen inactivating compounds, characterized in that the inner surface (14, 14a) is treated with a substance containing pathogen inactivating compounds, said substance comprising solvent and coniferous resin acids in the range of 0,01 to 30 weight-% of the substance.
- A method according to claim 1, wherein the method comprises a step of manufacturing a lining (18), said lining (18) having an inner surface (14a) and attaching the lining (18) inside the top layer (10), whereby the inner surface (14a) of the lining (18) forms the inner surface (14) of the glove.
- A method according to claim 1 or 2, wherein liquid containing pathogen inactivating compounds is sprayed on the inner surface (14, 14a) and the sprayed liquid is allowed to dry to a coating at least partly covering the inner surface (14, 14a).
- A method according to claim claims 1 or 2, wherein the glove is soaked in a liquid containing pathogen inactivating compounds to impregnate the glove with pathogen inactivating compounds and the soaked glove is allowed to dry.
- A method according to claim 2, wherein the lining (18) is soaked in a liquid containing pathogen inactivating compounds to impregnate the lining (18) with pathogen inactivating compounds and the soaked lining (18) is allowed to dry.
- A method according to claim 5, wherein the lining (18) is soaked in a liquid containing pathogen inactivating compounds before the lining (18) is attached inside the top layer (10).
- A method according to claim 2, wherein the lining (18) is manufactured of fabrics or of threads which fabrics or threads are treated with a substance containing pathogen inactivating compounds before the lining (18) is manufactured.
- A method according to any of the claims 2 to 7, wherein the top layer (10) is treated with a substance containing pathogen inactivating compounds before the lining (18) is attached inside the top layer (10).
- A glove comprising top layer (10), an outer surface (12) and an inner surface (14), which inner surface (14) is configured to be in skin contact when the glove is worn in hand and which inner surface (14) contains pathogen inactivating compounds, characterized in that said pathogen inactivating compounds comprise coniferous resin acids.
- The glove according to claim 9, comprising a lining (18) inside the top layer (10), said lining (18) having an inner surface (14a), whereby the inner surface (14a) of the lining (18) forms the inner surface (14) of the glove.
- A glove according to claim 9 or 10, wherein the inner surface (14, 14a) has a coating comprising pathogen inactivating compounds.
- The glove according to claims 10 or 11, wherein the top layer (10) and/or the lining (18) is impregnated with pathogen inactivating compounds.
- The glove according to any of the claims 9 to 12, wherein the top layer (10) is made of leather or textile and the outer surface (12) of the glove has a coating comprising pathogen inactivating compounds.
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20193029.4A EP3960013B1 (en) | 2020-08-27 | 2020-08-27 | Method of manufacturing a glove and a glove |
EP21172752.4A EP3960014A1 (en) | 2020-08-27 | 2021-05-07 | Method of manufacturing a glove and a glove |
CA3190911A CA3190911A1 (en) | 2020-08-27 | 2021-08-20 | Method of manufacturing a glove and a glove |
US18/023,167 US20230263249A1 (en) | 2020-08-27 | 2021-08-20 | Method of manufacturing a glove and a glove |
PCT/FI2021/050564 WO2022043606A1 (en) | 2020-08-27 | 2021-08-20 | Method of manufacturing a glove and a glove |
AU2021330354A AU2021330354A1 (en) | 2020-08-27 | 2021-08-20 | Method of manufacturing a glove and a glove |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20193029.4A EP3960013B1 (en) | 2020-08-27 | 2020-08-27 | Method of manufacturing a glove and a glove |
Publications (3)
Publication Number | Publication Date |
---|---|
EP3960013A1 EP3960013A1 (en) | 2022-03-02 |
EP3960013B1 true EP3960013B1 (en) | 2023-06-07 |
EP3960013C0 EP3960013C0 (en) | 2023-06-07 |
Family
ID=72266175
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP20193029.4A Active EP3960013B1 (en) | 2020-08-27 | 2020-08-27 | Method of manufacturing a glove and a glove |
EP21172752.4A Pending EP3960014A1 (en) | 2020-08-27 | 2021-05-07 | Method of manufacturing a glove and a glove |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP21172752.4A Pending EP3960014A1 (en) | 2020-08-27 | 2021-05-07 | Method of manufacturing a glove and a glove |
Country Status (5)
Country | Link |
---|---|
US (1) | US20230263249A1 (en) |
EP (2) | EP3960013B1 (en) |
AU (1) | AU2021330354A1 (en) |
CA (1) | CA3190911A1 (en) |
WO (1) | WO2022043606A1 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050112180A1 (en) * | 2003-11-22 | 2005-05-26 | Chou Belle L. | Antimicrobial elastomeric flexible article and manufacturing method |
US8499363B2 (en) * | 2006-07-28 | 2013-08-06 | Shen Wei (Usa) Inc. | Elastomeric flexible article with absorbent polymer and manufacturing method |
KR101111158B1 (en) * | 2009-01-16 | 2012-02-16 | 김영배 | Winter leather gloves |
AU2016312955B2 (en) * | 2015-08-25 | 2021-09-30 | Ansell Limited | Gloves having reinforcements and impact features |
-
2020
- 2020-08-27 EP EP20193029.4A patent/EP3960013B1/en active Active
-
2021
- 2021-05-07 EP EP21172752.4A patent/EP3960014A1/en active Pending
- 2021-08-20 US US18/023,167 patent/US20230263249A1/en active Pending
- 2021-08-20 CA CA3190911A patent/CA3190911A1/en active Pending
- 2021-08-20 WO PCT/FI2021/050564 patent/WO2022043606A1/en active Application Filing
- 2021-08-20 AU AU2021330354A patent/AU2021330354A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2021330354A1 (en) | 2023-04-13 |
EP3960013C0 (en) | 2023-06-07 |
EP3960013A1 (en) | 2022-03-02 |
WO2022043606A1 (en) | 2022-03-03 |
CA3190911A1 (en) | 2022-03-03 |
EP3960014A1 (en) | 2022-03-02 |
US20230263249A1 (en) | 2023-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20130022659A1 (en) | Band, bracelet or strip carrier for an anti-microbial agent to reduce the spread of disease | |
DE102011055154A1 (en) | Footwear piece i.e. sock, for covering and protecting foot, has knitted fabric for covering toes, foot area and joint area, and receiving elements provided for toes, where knitted fabric includes cut-resistant yarns | |
US9427035B2 (en) | Tattoo-revealing garment | |
EP3960013B1 (en) | Method of manufacturing a glove and a glove | |
JP4806740B2 (en) | Wig and manufacturing method thereof | |
KR101125964B1 (en) | Glove method and glove with inner layer and outer layer | |
KR101409235B1 (en) | Gyps for bone frature patients | |
US20040083530A1 (en) | Finger and palm protector for public use | |
KR20180008030A (en) | Manufacturing Method Of Water Resistance Glove And A Manufacturing Method Thereof Manufactured By Water Resistance Glove | |
EP3977883B1 (en) | Method of manufacturing a glove and a glove | |
US20220226163A1 (en) | Compression garment | |
US20040221354A1 (en) | Armpit Perspiration Absorber | |
JP3181349U (en) | Knitted gloves with pest repellent effect | |
KR200273767Y1 (en) | The Skin Protector for a Plaster Cast | |
KR200171402Y1 (en) | Band for preventing bathitch and eczema | |
JP3155825U (en) | Antiviral protective clothing | |
CN111093411B (en) | Humidity indicating garment | |
KR200440487Y1 (en) | Disposable foot socks for athlete`s foot | |
US20220049390A1 (en) | Medical protective clothing fabric | |
KR20210120357A (en) | glove | |
JPH01272875A (en) | Aromatic nonwoven fabric and aromatic sheet | |
KR100484964B1 (en) | interlining coated with ceramic powder and method for producing thereof | |
JPH02203856A (en) | Adhesive plaster | |
KR20160004782A (en) | Sheath with antifungal coating film for dealing with a viral acute infectious disease and manufacturing method of skin material with with antifungal coating film and manufacturing method of sheath with antifungal coating film for dealing with a viral acute infectious disease | |
KR20030047460A (en) | Mosquito repellent having sticker type |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20210430 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20220513 |
|
GRAJ | Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted |
Free format text: ORIGINAL CODE: EPIDOSDIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTC | Intention to grant announced (deleted) | ||
INTG | Intention to grant announced |
Effective date: 20221007 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP Ref country code: AT Ref legal event code: REF Ref document number: 1572057 Country of ref document: AT Kind code of ref document: T Effective date: 20230615 Ref country code: DE Ref legal event code: R096 Ref document number: 602020011671 Country of ref document: DE |
|
U01 | Request for unitary effect filed |
Effective date: 20230622 |
|
U07 | Unitary effect registered |
Designated state(s): AT BE BG DE DK EE FI FR IT LT LU LV MT NL PT SE SI Effective date: 20230628 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG9D |
|
U20 | Renewal fee paid [unitary effect] |
Year of fee payment: 4 Effective date: 20230915 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230907 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230607 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230607 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230607 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230908 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230607 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231007 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230607 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230607 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230607 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231007 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230607 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230607 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602020011671 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230607 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230607 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |